Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 17, 2019 09:25 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec Welcomes Updated CDC Recommendations for Tuberculosis Screening and Testing of Healthcare Personnel

OXFORD, United Kingdom and MARLBOROUGH, Mass., May 17, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced...
May 14, 2019 09:20 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec to Present at the UBS Global Healthcare Conference

OXFORD, United Kingdom and MARLBOROUGH, Mass., May 14, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced...
May 09, 2019 07:00 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec Reports First Quarter 2019 Financial Results

First quarter revenue of $14.8 million, an increase of 27% compared to prior year periodGross margins expanded 360bps to 71.4%86% reduction in net loss to $1.5m OXFORD, United Kingdom and...
April 25, 2019 16:05 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec Schedules First Quarter 2019 Earnings Release and Conference Call for May 9, 2019

OXFORD, United Kingdom and MARLBOROUGH, Mass., April 25, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today...
March 28, 2019 07:45 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec Announces New Initiative to Bring the Benefit of Modern Tuberculosis Testing to the Russian Federation

OXFORD, United Kingdom and MARLBOROUGH, Mass., March 28, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today...
March 21, 2019 16:01 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec Announces Chief Financial Officer Transition

OXFORD, United Kingdom and MARLBOROUGH, Mass., March 21, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today...
March 11, 2019 16:10 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec Reports Fourth Quarter and Full Year 2018 Financial Results

OXFORD, United Kingdom and MARLBOROUGH, Mass., March 11, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the "Company"), a global, high-growth diagnostics company, today...
March 05, 2019 09:00 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec to Participate in Two Upcoming Investor Conferences

OXFORD, United Kingdom and MARLBOROUGH, Mass., March 05, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that Dr. Peter...
February 19, 2019 16:45 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec Schedules Fourth Quarter and Full Year 2018 Earnings Release and Conference Call for March 11, 2019

OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced...
January 06, 2019 19:00 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec Announces Board Approval of $100 Million Share Repurchase Program and Reaffirms Growth Expectations for Fourth Quarter 2018

OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 06, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced...